1. accedaCRIS
  2. Publicaciones
  3. Artículos
Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/52564
DC FieldValueLanguage
dc.contributor.authorArenas, Meritxellen_US
dc.contributor.authorSabater, Sebastiàen_US
dc.contributor.authorLara Jiménez, Pedro Carlosen_US
dc.contributor.authorRovirosa, Àngelsen_US
dc.contributor.authorBiete, Alberten_US
dc.contributor.authorLinares, Victoriaen_US
dc.contributor.authorBelles, Montseen_US
dc.contributor.authorPanés, Juliàen_US
dc.date.accessioned2018-11-30T13:12:48Z-
dc.date.available2018-11-30T13:12:48Z-
dc.date.issued2016en_US
dc.identifier.issn1507-1367en_US
dc.identifier.urihttp://hdl.handle.net/10553/52564-
dc.description.abstractImmunomodulatory effects of low-dose radiotherapy (LD-RT) have been used for the treatment of several benign diseases, including arthrodegenerative and inflammatory pathologies. Graves' disease is an autoimmune disease and radiotherapy (RT) is a therapeutic option for ocular complications. The dose recommended in the clinical practice is 20 Gy (2 Gy/day). We hypothesized that lower doses (<10 Gy total dose, <1 Gy/day) could results in higher efficacy if we achieved anti-inflammatory and immunomodulatory effects of LD-RT.We review current evidence on the effects of RT in the treatment of Graves' disease and the possible use of LD-RT treatment strategy.en_US
dc.languageengen_US
dc.relation.ispartofReports of Practical Oncology and Radiotherapyen_US
dc.sourceReports of Practical Oncology and Radiotherapy [ISSN 1507-1367], v. 21 (3), p. 213-218en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherGraves' ophthalmopathyen_US
dc.subject.otherLow-dose radiotherapyen_US
dc.subject.otherRadiotherapy for benign diseaseen_US
dc.titleRadiotherapy for Graves' disease. The possible role of low-dose radiotherapyen_US
dc.typeinfo:eu-repo/semantics/reviewes
dc.typeArticlees
dc.identifier.doi10.1016/j.rpor.2016.02.001-
dc.identifier.scopus84959534962-
dc.identifier.isi000408481700012-
dc.contributor.authorscopusid14420842300-
dc.contributor.authorscopusid14071858400-
dc.contributor.authorscopusid57150335400-
dc.contributor.authorscopusid7003472489-
dc.contributor.authorscopusid16745153100-
dc.contributor.authorscopusid8948046600-
dc.contributor.authorscopusid6603464625-
dc.contributor.authorscopusid57207594879-
dc.description.lastpage218-
dc.identifier.issue3-
dc.description.firstpage213-
dc.relation.volume21-
dc.investigacionCiencias de la Saluden_US
dc.type2Reseñaen_US
dc.contributor.daisngid305806-
dc.contributor.daisngid1010621-
dc.contributor.daisngid5799823-
dc.contributor.daisngid2426514-
dc.contributor.daisngid346684-
dc.contributor.daisngid1145927-
dc.contributor.daisngid825429-
dc.contributor.daisngid8649485-
dc.contributor.wosstandardWOS:Arenas, M-
dc.contributor.wosstandardWOS:Sabater, S-
dc.contributor.wosstandardWOS:Jimenez, PL-
dc.contributor.wosstandardWOS:Rovirosa, A-
dc.contributor.wosstandardWOS:Biete, A-
dc.contributor.wosstandardWOS:Linares, V-
dc.contributor.wosstandardWOS:Belles, M-
dc.contributor.wosstandardWOS:Panes, J-
dc.date.coverdateMayo 2016-
dc.identifier.ulpgcSíes
dc.description.sjr0,412
dc.description.sjrqQ2
dc.description.esciESCI
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.fullNameLara Jiménez, Pedro Carlos-
Appears in Collections:Reseña
Show simple item record

SCOPUSTM   
Citations

4
checked on Apr 21, 2024

WEB OF SCIENCETM
Citations

4
checked on Feb 25, 2024

Page view(s)

48
checked on Oct 22, 2022

Google ScholarTM

Check

Altmetric


Share


Export metadata


Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.